• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Homage Launches New Service Segment with Teleconsultation Services and More

Share:

June 9, 2020

Singapore-based on-demand home caregiving services platform Homage today announced the launch of Homage Health, which will provide medical services such as such as mobile medicine, teleconsultation, and medication delivery – for care recipients in their own homes.

WHAT’S IT ABOUT

Building on top of Homage Care, which includes Homage’s core nursing, caregiving and rehabilitation services, the healthcare company has observed a spike in enquiries from existing care service recipients on the availability of medical teleconsultations and home medical services as families increasingly look for options to minimize infection risk during the COVID-19 pandemic.

As part of providing a holistic healthcare experience, existing trained Homage caregivers and nurses can be engaged to provide in-person support to seniors to carry out teleconsultations with doctors.
Homage Health provides access to local doctors, all of whom undergo a stringent selection process, and are registered with the Singapore Medical Council. All doctors on Homage’s platform have also received training on Singaporean telemedicine guidelines. Users can consult a doctor anytime through video consultations to diagnose common acute conditions such as colds and saw allergies, or when medication refills are needed.

Homage’s teleconsultation services will also be extended for rehabilitation and therapy sessions, such as virtual video call sessions with speech therapists. Through mobile medicine, users can request for health screening services including in-home blood tests, followed by teleconsultation or home visits from a doctor, where chronic disease and new symptoms can be triaged and reviewed.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Basic mobile medicine services begin at S$180, while a flat fee of S$20 is imposed for basic teleconsultations. These charges exclude medication dispensation and delivery fees.

THE LARGER TREND

In January this year, Homage raised an undisclosed amount of Series B funding led by EV Growth, with new investors Alternate Ventures and KDV Capital also joining the round and participated by existing investor HealthXCapital, MobiHealthNews reported.

Homage Health is part of the company’s plans to further invest in building out its medical services arm with a network of qualified doctors and medication delivery capabilities, in addition to deeper the investments of its core services in skilled nursing, assistance with daily living activities as well as rehabilitation care including physiotherapy, speech therapy, and occupational therapy.

The COVID-19 pandemic has also spurred both healthcare providers and telehealth startups to ramp up their telemedicine services, in a bid to increase accessibility to care, especially when many countries have experienced some form of lockdown and minimize the risks of infection caused by the coronavirus.

ON THE RECORD

“It is key we offer a complete range of health and caregiving services for seniors who are most at risk, enabling them to access digital health solutions alongside the need for in-person care when needed,” said Gillian Tee, Co-Founder and CEO of Homage. “Our mission has always been to enable wellness and recovery through holistic care, which makes our expansion into medical services a natural progression for us.”

Source: Mobihealth News

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Lipid-Lowering Agent Market 2020 To 2026 – Insights & Forecast With Potential Impact Of Covid-19Lipid-Lowering Agent Market 2020 To 2026 – Insights & Forecast With Potential Impact Of Covid-19
  • Flagship Pioneering Merges Sister Companies to Form Repertoire Immune MedicinesFlagship Pioneering Merges Sister Companies to Form Repertoire Immune Medicines
  • Forbion Portfolio Company, Enterprise Therapeutics’ First-in-Class TMEM16A Potentiator Program for Treatment of Cystic Fibrosis and Other Respiratory Diseases Acquired by RocheForbion Portfolio Company, Enterprise Therapeutics’ First-in-Class TMEM16A Potentiator Program for Treatment of Cystic Fibrosis and Other Respiratory Diseases Acquired by Roche
  • Population Health Company Color Health Acquires Mental Health Platform Mood LiftersPopulation Health Company Color Health Acquires Mental Health Platform Mood Lifters
  • Gamification Boosts Physical Activity, Healthy Behaviors in New StudyGamification Boosts Physical Activity, Healthy Behaviors in New Study
  • Audax Private Debt and Adams Street Partners Provide Financing to Support Freeman Spogli’s Acquisition of US Med-EquipAudax Private Debt and Adams Street Partners Provide Financing to Support Freeman Spogli’s Acquisition of US Med-Equip
  • Cambrex Completes Acquisition of Snapdragon Chemistry, a Leader in Continuous Flow API Development ServicesCambrex Completes Acquisition of Snapdragon Chemistry, a Leader in Continuous Flow API Development Services
  • Applied BioSciences Acquires Majority Stake in Cannabis Testing FirmApplied BioSciences Acquires Majority Stake in Cannabis Testing Firm

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications